Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events
Concomitant Drug Interactions With Nonâ€“Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation
Risk of bleeding with the concurrent use of amiodarone and DOACs: a systematic review and meta-analysis
